Psychopathology, insight and compliance in schizophrenia

Irish Journal of Psychological Medicine

Volumn 26, Issue 1, 2009, Pages 12-15

  Bajaj, Vikrant ^a   Sengupta, Somnath ^a   Gupta, Dhanesh Kumar ^a  

^a INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

Compliance; Insight; Psychopathology; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; INSIGHT AND TREATMENT ATTITUDE QUESTIONNAIRE; INTROSPECTION; LONG TERM CARE; LONGITUDINAL STUDY; MALE; MARRIAGE; MEDICATION ADHERENCE RATING SCALE; MENTAL DISEASE; ONSET AGE; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; QUESTIONNAIRE; RATING SCALE; SCHIZOPHRENIA; SHORT COURSE THERAPY; TREATMENT DURATION;

EID: 81555204078     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700000057     Document Type: Article

References (29)

1. Fenton WS, Blyler CR. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schiz Bull 1997; 23(4): 637-651.
2. Robinson D, Woerner MG. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241-247.
3. Jeffreys SE, Harvey CA. The Hampstead Schizophrenia Survey 1991: prevalence and service use comparisons in an inner London health authority, 1986-1991. Br J Psychiatry 1997; 170: 301-306.
4. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 2000; 101: 119-124.
5. McCabe R, Quayle E. Is there a role for compliance in the assessment of insight in chronic schizophrenia? Psychology, health and medicine 2000; 5(2):173-178.
6. McEvoy JP, Freter S. Insight and clinical outcome of schizophrenic patients. J Nerv Ment Dis 1989; 177: 48-51.
7. Cuffel BJ, Alford J. Awareness of illness in schizophrenia and outpatient treatment adherence. J Ner Ment Dis 1996; 184(11): 653-659.
8. Rittmannsberger H, Pachinger T. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr Serv 2004; 55: 174-179.
9. Marder SR, Mebane A. A comparison of patients who refuse and consent to neuroleptic treatment. Am J Psychiatry 1983;140: 470-472.
10. Verdoux H, Lengronne J. Medication adherence in psychosis: predictors and impact on outcome. A 2 year follow up of first admitted subjects. Acta Psychiatr Scand 2000; 102: 203-210
11. David A, Buchanan A, Reed A. The assessment of insight in psychosis. Br J Psychiatry 1992; 161: 599-602.
12. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva, World Health Organization, 1992.
13. McEvoy JP, Apperson IJ. Insight in schizophrenia: its relationship to acute psychopathology. J Nerv Ment Dis 1989; 177: 43-47.
14. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr Bull 1987; 13: 261-276.
15. Thompson K, Kulkarni J. Reliability and validity of a new medication adherence rating scale for the psychoses. Schizophr Res 2000; 102: 241-247.
16. Kulhara P, Chakravarty S, Basu D. Insight and psychosis: An empirical enquiry. Ind J Soc Psychiatry 1992; 8: 40-44.
17. Trauer T, Sacks T. The relationship between insight and medication adherence in severely mentally ill clients treated in community. Acta Psychiatr Scand 2000; 102: 211-216.
18. Lincoln AKP, Chandrasekharan R. Insight, psychopathology and schizophrenia. Ind J Psychiatry 2002; 44(4): 332-336.
19. Heinrichs DW, Cohen BP, Carpenter WT. Early insight and the management of schizophrenic decompensation. J Nerv Ment Dis 1985; 173(3): 133-138.
20. Amador XF, Strauss DH. The assessment of insight in psychosis. Am J Psychiatry 1993; 150: 873-879.
21. Cuesta MJ, Peralta V. Lack of insight in schizophrenia. Schizophr Bull 1994; 20(2): 359-366.
22. Aga VM, Agarwal AK, Gupta SC. The relationship of insight to psychopathology in schizophrenia. Ind J Psychiatry 1995; 37(3): 129-135.
23. Tattan TMG, Creed FH. Negative symptoms of schizophrenia and compliance with medication. Schizophr Bull 2001; 27(1): 149-155.
24. Mehrotra S, Sengupta SN. Insight and psychopathology in schizophrenia: A four week longitudinal study. German J Psychiatry 2005; 8: 48-52.
25. Lin IF, Spiga R. Insight and adherence to medication in chronic schizophrenia. J Clin Psychiatry 1979; 40(10): 430-432.
26. Tharyan A, Saravanan B. Insight and psychopathology in schizophrenia. Ind J Psychiatry 2000; 42(4): 421-426.
27. Saravanan B, Jacob KS. Assessing insight in schizophrenia: East meets west. Br J Psychiatry 2007; 190: 243-247.
28. Bartko G, Hertzeg I, Zador G. Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatr Scand 1988; 77: 74-76.
29. Dervaux A, Bayle FJ, Laqueille X et al. Nicotine use in schizophrenia and disinhibition. Psychiatry Res 2004; 128(3): 229-234.